Biotech

Career and Jobs News

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 02.12.2021.

#covidnews
#covid19
#biopharma
#genetherapy
#medicalnews
#biotech
#lifesciences

Career And Jobs

@biospace shared
On Nov 30, 2021
Omicron variant has vaccine makers moving fast and more COVID news #covid19 #covidnews https://t.co/Y9OazH7ixf
Open
Omicron Variant has Vaccine Makers Moving Fast and More COVID News

Omicron Variant has Vaccine Makers Moving Fast and More COVID News

Omicron has caused the U.S. to install travel bans against several South African countries while vaccine makers rush to test their vaccines against it. For that news and more, continue ...

@biospace shared
On Nov 29, 2021
Gene-based therapy for rare skin disease succeeds in phase III #genetherapy #biopharma https://t.co/LaU2LqPRJz
Open
Gene-Based Therapy for Rare Skin Disease Succeeds in Phase III

Gene-Based Therapy for Rare Skin Disease Succeeds in Phase III

Results from its GEM-3 trial on VYJUVEK demonstrated statistical significance in its ability to promote complete wound healing within six months compared to a placebo.

@biospace shared
On Nov 29, 2021
Boston neighbors net $256 million for Treg and Allosteric therapies #biotech #medicalnews https://t.co/OxmDI0uorO
Open
Boston Neighbors Net $256 Million for Treg and Allosteric Therapies

Boston Neighbors Net $256 Million for Treg and Allosteric Therapies

Quell Therapeutics scooped up $156 million in a Series B round this week. The company utilizes regulatory T cells to treat a variety of autoimmune and inflammatory diseases.

@MassBioEd shared
On Dec 1, 2021
"Some of the fastest growing careers today require more than a high school diploma but not necessarily a 4-year degree" MassBioEd has designed one of the 1st Life Sciences Apprenticeship Programs in the U.S. to help facilitate new opportunities. Read more: https://t.co/eTTSkPqMAs
Open
Apprenticeships create new pathways into life sciences

Apprenticeships create new pathways into life sciences

DURING THIS EXCITING  time of growth for biotech and the life sciences industry in Massachusetts, the future of this industry depends on growing the pool of trained, qualified workers. ...

@MassBio shared
On Nov 30, 2021
Following the release of our report on the state of diversity in MA #lifesciences, Senior Director of DEI Warner Santiago breaks down the numbers and talks through what these results mean for the ecosystem. Read more on our blog: https://t.co/gfZDBtZMxr
Open
Progress and Opportunity: Unpacking MassBio’s DEI Report and Actionable Next Steps

Progress and Opportunity: Unpacking MassBio’s DEI Report and Actionable Next Steps

At MassBio, we are committed to working with our members and partners to design meaningful approaches to look at diversity, equity, and inclusion through an intersectional lens. In honor of ...

@JohnCendpts shared
On Dec 1, 2021
RT @JMaraganore: Thrilled to be joining ARCH as a Venture Partner as part of my plan to work with leading VCs! Looking forward to working w/ the team & the next generation of biotechs to advance promising science that can improve patients' lives. https://t.co/qK3yYXu5Vo
Open
ARCH Venture Partners Announces Several Key Appointments

ARCH Venture Partners Announces Several Key Appointments

/PRNewswire/ -- ARCH Venture Partners, one of the world's leading early-stage technology venture firms, today announced new Venture Partners, including John...

@JohnCendpts shared
On Dec 2, 2021
@JMaraganore is going to be the busiest retired biotech CEO in the biz -- Bob Nelsen woos John Maraganore to his first VC post after retiring from Alnylam By @AmberTongPW https://t.co/RfteJFNlpT
Open
Bob Nelsen woos John Maraganore to his first VC post after retiring from Alnylam

Bob Nelsen woos John Maraganore to his first VC post after retiring from Alnylam

After almost two decades of primarily being known as Alnylam’s CEO, John Maraganore is getting a new, prominent title. Maraganore is among a slate of new venture partners at ARCH Venture, ...

@FierceBiotech shared
On Dec 1, 2021
Neither company has disclosed the terms of the deal. Origimm kept a fairly low profile over its nine-year history, disclosing a series A financing in 2016, without revealing the size of the round, and additional cash from an Austrian funding scheme in 2018 https://t.co/UOBgYYlclT
Open
Sanofi snaps up Origimm for early-phase acne vaccine, opening new front in mRNA strategy

Sanofi snaps up Origimm for early-phase acne vaccine, opening new front in mRNA strategy

Sanofi is adding another thread to its mRNA strategy. Having already bagged Translate Bio’s mRNA platform, Sanofi is now snapping up Origimm Biotechnology to land a therapeutic acne vaccine ...

Read more: Career And Jobs
weekly 02.12.2021
View archives
Back to home

Subscribe to Biotech - Career and Jobs.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Career and Jobs.
Privacy Policy

Sign up for the weekly Biotech - Career and Jobs newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Career and Jobs weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy